Cost-Effectiveness Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Venous Thromboembolism in China

Background: The drug therapy of venous thromboembolism (VTE) presents a significant economic burden to the health-care system in low- and middle-income countries. To understand which anticoagulation therapy is most cost-effective for clinical decision-making , the cost-effectiveness of apixaban (API...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ke-Xin, Cui, Bin, Cao, Shan-Shan, Huang, Qi-Xiang, Xia, Ru-Yi, Wang, Wen-Jun, Wang, Jing-Wen, Yu, Feng, Ding, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563621/
https://www.ncbi.nlm.nih.gov/pubmed/34744710
http://dx.doi.org/10.3389/fphar.2021.716224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563621/
https://www.ncbi.nlm.nih.gov/pubmed/34744710
http://dx.doi.org/10.3389/fphar.2021.716224

Ejemplares similares